Form EFFECT Propanc Biopharma, Inc.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | February 24, 2026 12:00 P.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Propanc Biopharma plans Phase 1b cancer drug trial for February 2027
- NL2 Capital Inc. Announces $3.5 Million to $10 Million Concurrent Financing in Connection with Proposed Qualifying Transaction
- Xfinity Mobile, Comcast Business Mobile to Offer iPhone Duo, iPhone 18 Pro, and iPhone 18 Pro Max
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
